Claire Moore

8PUBLICATIONS
35CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersToxicology (incl. clinical toxicology)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 10, 2026
Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study.

|Apr 14, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 Update.

Claire Moore, Melissa S Bourque, Andreas Halman

|May 10, 2025
Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort.

Claire Moore, Andreas Halman, Tayla Stenta

|Apr 22, 2025
Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study.

Rachel Conyers, Tayla Stenta, Andrew A Somogyi

|Feb 03, 2025
CYP2D6 genotype and associated 5-HT3 receptor antagonist outcomes: A systematic review and meta-analysis.

Claire Moore, Elizabeth Williams, Roxanne Dyas

|Sep 30, 2024
Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.

Andreas Halman, Rachel Conyers, Claire Moore

Pageof 2

Frequent Collaborators

8 joint publications

Rachel Conyers

7 joint publications

Andreas Halman

5 joint publications

Dhrita Khatri

4 joint publications

Elizabeth Williams